SCHEMBL7777683

SCHEMBL7777683

CSc1ccc(-c2nn(C)c(C(F)(F)F)c2-c2ccc(F)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.49
PTGS2 P35354 7/20 0.46
MAPK13 O15264 5/20 0.46
MAPK12 P53778 5/20 0.46
MAPK11 Q15759 5/20 0.46
GCGR P47871 4/20 0.46
PTGS1 P23219 1/20 0.46
SRC P12931 1/20 0.41
BRAF P15056 1/20 0.41
KDR P35968 1/20 0.41
GABRP O00591 2/20 0.40
GABRD O14764 2/20 0.40
GABRA1 P14867 2/20 0.40
GABRB1 P18505 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA5 P31644 2/20 0.40
GABRA3 P34903 2/20 0.40
GABRA2 P47869 2/20 0.40
GABRB2 P47870 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777933 0.84 PTGS2 (0.56) PTGS2PTGS1
SCHEMBL7779784 0.83 PTGS2 (0.56) MAPK14PTGS2PTGS1ALOX5
SCHEMBL8765299 0.82 SRC (0.48) MAPK14PTGS2MAPK13MAPK12MAPK11
SCHEMBL7780920 0.79 PTGS2 (0.51) MAPK14PTGS2MAPK13MAPK12MAPK11
SCHEMBL7772902 0.79 PTGS2 (0.72) PTGS2PTGS1
SCHEMBL7773298 0.78 MAPK14 (0.49) MAPK14PTGS2MAPK13MAPK12MAPK11
SCHEMBL7780017 0.78 PTGS2 (0.73) MAPK14PTGS2PTGS1
SCHEMBL6044333 0.77 PTGS2 (0.46) MAPK14PTGS2MAPK13MAPK12MAPK11
SCHEMBL8632198 0.74 PTGS2 (0.41) PTGS2PTGS1GABRPGABRDGABRA1
SCHEMBL16200053 0.74 SLC34A1 (0.44) MAPK14PTGS2MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed